Ospedale Santa Maria delle Croci di Ravenna

Ravenna 48121

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Nucleophosmin 1-mutated Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
• Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML — Stopped early